Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ: VRTX )

445.81 +0.60 (+0.13%)
Streaming Delayed Price Updated: 10:20 AM EDT, May 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vertex Pharmaceuticals

< Previous 1 2
...
11 12 13 14 15 16 17 18 19
...
47 48 Next >
3 No-Brainer Growth Stocks to Buy in October
The time is right to invest in these great stocks. 
Via The Motley Fool
Jim Cramer: This Company Is 'Arranging Deck Chairs On The Titanic... Not A Believer'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Topgolf Callaway Brands Corp. (NYSE: MODG) is making money. 
Via Benzinga
HP, Zoom Video And 2 Other Stocks Insiders Are Selling
The Nasdaq 100 closed lower by over 50 points on Thursday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
Is VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX) suited for quality investing?
VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX) may be suited for quality investing, we'll explore why in this article. 
Via Chartmill
Biotech Sector: On The Verge Of Triumph Or Turmoil?
In this article, we delve into the Biotech Sector, exploring its promises, potential pitfalls, and the questions that arise. 
Via Talk Markets
Got $1,000? 2 No-Brainer Stocks to Buy
You can bet the farm on these companies. 
Via The Motley Fool
$100 Invested In Vertex Pharmaceuticals 15 Years Ago Would Be Worth This Much Today
Via Benzinga
Analyst Ratings for Vertex Pharmaceuticals
Via Benzinga
Looking Into Vertex Pharmaceuticals's Recent Short Interest
Via Benzinga
Vertex Appoints Michel Lagarde to its Board of Directors
From Vertex Pharmaceuticals Incorporated
Via Business Wire
3 No-Brainer Stocks to Buy With $1,000 Right Now
A modest amount of money can go a long way when it's invested in highly profitable industry leaders with sustained competitive advantages. 
Via The Motley Fool
Vertex Presents Positive, Updated VX-880 Results From Ongoing Phase 1/2 Study in Type 1 Diabetes at the European Association for the Study of Diabetes 59th Annual Meeting
From Vertex Pharmaceuticals Incorporated
Via Business Wire
This Is What Whales Are Betting On Vertex Pharmaceuticals
Via Benzinga
Biotechnology Breakthroughs: 3 Biotech Stocks That Could Make Early Investors Rich
Are you looking to invest in biotechnology breakthroughs? Here are three biotech stocks that could make early investors rich. 
Via InvestorPlace
Cathie Wood Is Buying This Growth Stock Hand Over Fist Lately. Should You Follow Her Lead?
The Internet's most famous innovation-focused investor is excited about this company's innovative approach to editing the human genome. 
Via The Motley Fool
2 Top Biotech Stocks to Buy in October
Growth catalysts lie ahead for both of these players. 
Via The Motley Fool
3 Magnificent Stocks That Are Screaming Buys in October
These stocks give investors something to yell about -- in a good way. 
Via The Motley Fool
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation
These companies are helping change medicine; they could make boatloads of money along the way. 
Via The Motley Fool
2 Brilliant Growth Stocks to Invest $2,000 in Right Now
These growth companies are capitalizing on underserved target markets. 
Via The Motley Fool
5 Top Stocks for October
Venture into October's investment landscape with our five experts, unveiling opportunities in an uneven market environment. 
Via The Motley Fool
Moonshot Medicine: 3 Stocks to Buy to Bet on Long-Shot Drugs
The best drug stocks to buy now are shooting for the moon. These three trailblazers will land among the stars. 
Via InvestorPlace
The Best Stocks to Invest $5,000 in Right Now
Now is a great time to buy Amazon, Enterprise Products Partners, and Vertex Pharmaceuticals. 
Via The Motley Fool
Why Editas Medicine Stock Is Soaring Today
Investors are cheering a big analyst upgrade for the gene-editing stock. 
Via The Motley Fool
Crispr Therapeutics, And CRISPR Gene-Editing, Face Their Make-Or-Break Moment
The FDA is within three months of making a decision on the first-ever CRISPR-based drug. 
Via Investor's Business Daily
Exposures Product Safety
Don’t Miss the Boom: 3 Pharma Stocks Set to Explode Higher
These pharma stocks could boom in the coming years, riding their diversified pipelines with massive addressable markets higher. 
Via InvestorPlace
Three Of Our Top Picks For Your Healthcare Portfolio
Amidst macro uncertainty, healthcare stocks should outperform. 
Via Talk Markets
Don’t Miss the Boom: 3 Biotech Stocks Set to Explode Higher
With their seamless blend of promise and innovation, these biotech stocks to buy offer a strategic gateway to fortify your portfolio. 
Via InvestorPlace
Buying These 2 Remarkable Growth Stocks in Any Market Could Be a Genius Move
Great companies haven't gone anywhere. 
Via The Motley Fool
3 Magnificent Growth Stocks to Buy Right Now
If you're looking for growth, these stocks could be just the ticket. 
Via The Motley Fool
Meta Stock Leads 5 Names Showing Resilience In Market Downturn
These stocks have held up so far, but patience is key amid the correction. 
Via Investor's Business Daily
< Previous 1 2
...
11 12 13 14 15 16 17 18 19
...
47 48 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.